SCHEMBL25000213

SCHEMBL25000213

c1ccc(-c2ccc(N(c3ccc(-c4ccc(-c5ccccc5)c(-c5ccccc5)c4)cc3)c3ccc(-c4cccc5c4oc4ccccc45)cc3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.51
▸ GGPS1 O95749 1/20 0.41
▸ PRKDC P78527 7/20 0.39
▸ PTGES2 Q9H7Z7 1/20 0.39
▸ CDC14B O60729 2/20 0.38
▸ CDC14A Q9UNH5 2/20 0.38
▸ PLA2G2A P14555 3/20 0.37
▸ PLA2G4A P47712 3/20 0.37
▸ PLA2G10 O15496 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ ATM Q13315 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ APAF1 O14727 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ XBP1 P17861 1/20 0.35
▸ PTBP1 P26599 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12694860 1.00 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL24999258 0.99 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL25628759 0.96 ALOX5 (0.48) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL24862177 0.96 ALOX5 (0.53) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL31593187 0.96 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL24862048 0.96 ALOX5 (0.53) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL25000326 0.95 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL25000230 0.95 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL23438458 0.95 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL25628892 0.95 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2CDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-22 — — US disclosed
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-22 — — US disclosed
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-06-13 — — US disclosed
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-06-13 — — US disclosed
EP-4129972-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Idemitsu Kosan Co.,Ltd. (JP) 2023-02-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ALOX5 1914/4885GGPS1 2947/4885PRKDC 4304/4885
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device PIEZO1, LEF1, L1CAM ALOX5 1914/4885GGPS1 2947/4885PRKDC 4304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback